Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Post by lscfaon Apr 12, 2021 9:15pm
364 Views
Post# 32982815

Insider buying

Insider buying

Sativa Wellness Group Inc. Announces PDMR Director Disclosure

Monday, April 12, 2021 7:55 PM
Share this article now
  
Topic: 
 
Regulatory
 

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

VANCOUVER, BC / ACCESSWIRE / April 12, 2021 / Sativa Wellness Group Inc. (CSE:SWEL)(OTC PINK:SCNNF) ("Sativa Wellness" or the "Company") announces that as part of the recent closure of the first tranche of its non-brokered private placement of units of the Company (each, a "Unit") previously announced on April 9, 2021 (the "Placement") Clive Standish, one of the board of directors took part.

Before this placement Clive Standish held 83,768 shares and 83,768 warrants in Sativa Wellness. As part of this placement Exhall Pty Ltd, a company related to Clive Standish, purchased 13,000,000 Units at a price of C$0.07875 per Unit for aggregate gross proceeds of C$1,023,750. Each Unit is comprised of one common share (each, a "Share") and one-half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder to purchase one common share in the capital of the Company (a "Warrant Share") at a price of C$0.105 per Warrant Share until March 31, 2023.

The total number of shares Clive has an interest in directly or indirectly is 13,083,768 common shares which represents 3.73% of the company's shares and the total number of warrants he has an interest in is 6.586,768.

The securities issued under the first tranche of the Offering will be subject to a statutory hold period expiring on August 1, 2021, in accordance with applicable Canadian securities laws.

The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration on applicable exemption from the registration requirements. This news release will not constitute an offer to sell or the solicitation of an offer to buy nor will there by any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.

All references to currency in this news release are to Canadian currency.

For further information regarding Sativa Wellness, see Sativa Wellness' disclosure documents on SEDAR at www.sedar.com.

On behalf of the Board of Directors,

Geremy Thomas
Executive Chairman
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com www.sativawellnessgroup.com

Anne Tew
Corporate Secretary
Sativa Wellness Group Inc.
+44 (0) 20 7971 1255
enquiries@sativawellnessgroup.com www.sativawellnessgroup.com


<< Previous
Bullboard Posts
Next >>